$PHM
PULTEGROUP INC/MI/ Stock $phm

$phm Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000082241623000017 Filed on April 25, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$4.189B	$3.576B	$5.171B
YoY Change	6.69%	12.17%	18.65%
Cost Of Revenue	$2.936B	$2.541B	$3.674B
YoY Change	8.45%	12.62%	16.11%
Gross Profit	$1.253B	$1.034B	$1.498B
YoY Change	2.77%	11.09%	25.37%
Gross Profit Margin	29.92%	28.93%	28.96%
Selling, General & Admin	$314.6M	$336.5M	$350.8M
YoY Change	-10.43%	2.28%	1.92%
% of Gross Profit	25.11%	32.54%	23.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.07M	$19.14M	$18.98M
YoY Change	16.58%	18.28%	12.13%
% of Gross Profit	1.6%	1.85%	1.27%
Operating Expenses	$314.7M	$336.5M	$351.8M
YoY Change	-10.39%	2.28%	1.96%
Operating Profit	$938.4M	$697.8M	$1.146B
YoY Change	8.1%	15.91%	34.87%
Interest Expense	$16.13M	$9.502M	$49.15M
YoY Change	1601.05%	523.49%	313.82%
% of Operating Profit	1.72%	1.36%	4.29%
Other Income/Expense, Net	$13.59M	$1.818M
YoY Change	-488.39%	-185.03%
Pretax Income	$953.0M	$702.1M	$1.164B
YoY Change	10.23%	17.04%	35.97%
Income Tax	$232.7M	$169.9M	$281.6M
% Of Pretax Income	24.41%	24.19%	24.19%
Net Earnings	$717.9M	$532.3M	$877.0M
YoY Change	10.03%	17.05%	32.22%
Net Earnings / Revenue	17.14%	14.89%	16.96%
Basic Earnings Per Share	$3.23	$2.35
Diluted Earnings Per Share	$3.21	$2.35	$3.85
COMMON SHARES
Basic Shares Outstanding	223.2M shares	225.6M shares	227.8M shares
Diluted Shares Outstanding	223.4M shares	226.0M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.729B	$1.278B	$1.053B
YoY Change	160.83%	11.62%	-40.81%
Cash & Equivalents	$1.729B	$1.278B	$1.053B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$11.34B	$11.43B	$11.33B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$13.06B	$12.71B	$12.38B
YoY Change	14.67%	15.39%	14.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$73.00M	$72.90M	$200.3M
YoY Change	3.11%	2.68%	34.27%
Goodwill	$68.93M	$68.93M	$68.93M
YoY Change
Intangibles			$135.8M
YoY Change			-7.57%
Long-Term Investments	$583.8M	$144.7M	$146.8M
YoY Change	287.9%	36.4%	49.56%
Other Assets	$152.3M	$176.2M	$166.1M
YoY Change	-31.58%	-20.57%	-25.47%
Total Long-Term Assets	$2.162B	$2.121B	$2.417B
YoY Change	-6.32%	-1.31%	-4.3%
TOTAL ASSETS
Total Short-Term Assets	$13.06B	$12.71B	$12.38B
Total Long-Term Assets	$2.162B	$2.121B	$2.417B
Total Assets	$15.23B	$14.83B	$14.80B
YoY Change	11.14%	12.66%	10.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$543.4M	$488.8M	$566.0M
YoY Change	-27.59%	-22.27%	-8.89%
Accrued Expenses	$1.536B	$1.675B	$1.586B
YoY Change	0.01%	9.83%	0.64%
Deferred Revenue
YoY Change
Short-Term Debt	$315.6M	$324.4M	$586.7M
YoY Change	-28.73%	-18.1%	-6.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.192B	$3.285B	$3.523B
YoY Change	-15.04%	-7.45%	-3.97%
LONG-TERM LIABILITIES
Long-Term Debt	$2.033B	$2.042B	$2.046B
YoY Change	0.15%	0.57%	0.81%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.033B	$2.042B	$2.046B
YoY Change	0.15%	0.57%	0.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.192B	$3.285B	$3.523B
Total Long-Term Liabilities	$2.033B	$2.042B	$2.046B
Total Liabilities	$5.521B	$5.567B	$5.882B
YoY Change	-7.29%	-3.19%	0.33%
SHAREHOLDERS EQUITY
Retained Earnings			$5.582B
YoY Change			33.02%
Common Stock			$2.258M
YoY Change			-9.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.705B	$9.264B	$8.914B
YoY Change
Total Liabilities & Shareholders Equity	$15.23B	$14.83B	$14.80B
YoY Change	11.14%	12.66%	10.81%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	$717.9M	$532.3M	$877.0M
YoY Change	10.03%	17.05%	32.22%
Depreciation, Depletion And Amortization	$20.07M	$19.14M	$18.98M
YoY Change	16.58%	18.28%	12.13%
Cash From Operating Activities	$739.2M	$711.4M	$972.4M
YoY Change	-801.86%	242.55%	113.34%
INVESTING ACTIVITIES
Capital Expenditures	$21.33M	$23.74M	$24.08M
YoY Change	-166.94%	-22.63%	-216.61%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$8.449M	$1.570M	$7.023M
YoY Change	-80.49%	688.94%	-141.27%
Cash From Investing Activities	-$29.78M	-$24.21M	-$17.05M
YoY Change	-60.38%	-49.52%	-54.72%
FINANCING ACTIVITIES
Cash Dividend Paid		$36.38M
YoY Change		-3.75%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$4.500M
YoY Change
Cash From Financing Activities	-258.5M	-$454.9M	-152.2M
YoY Change	-13.62%	-41.79%	-27.26%
NET CHANGE
Cash From Operating Activities	739.2M	$711.4M	972.4M
Cash From Investing Activities	-29.78M	-$24.21M	-17.05M
Cash From Financing Activities	-258.5M	-$454.9M	-152.2M
Net Change In Cash	450.9M	$232.3M	803.2M
YoY Change	-193.99%	-137.37%	284.44%
FREE CASH FLOW
Cash From Operating Activities	$739.2M	$711.4M	$972.4M
Capital Expenditures	$21.33M	$23.74M	$24.08M
Free Cash Flow	$717.9M	$687.6M	$948.3M
YoY Change	-1077.35%	288.53%	99.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	PULTEGROUP INC/MI/
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000822416
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-9804
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MI
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-2766606
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3350 Peachtree Road NE, Suite 1500
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30326
CY2023Q1	dei	City Area Code CityAreaCode	404
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	978-6400
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	223224233	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1278025000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1053104000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	48829000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	41449000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1326854000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1094553000	usd
CY2023Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	11431877000	usd
CY2022Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	11326017000	usd
CY2023Q1	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	48036000	usd
CY2022Q4	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	42254000	usd
CY2023Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	420638000	usd
CY2022Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	677207000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	144664000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	146759000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	1246492000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	1291572000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	68930000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	68930000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	64205000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	66875000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	79346000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	82348000	usd
CY2023Q1	us-gaap	Assets Assets	14831042000	usd
CY2022Q4	us-gaap	Assets Assets	14796515000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	488757000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	565975000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	796384000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	783556000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	240604000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	215446000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1675404000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1685202000	usd
CY2023Q1	phm	Financial Services Debt FinancialServicesDebt	324447000	usd
CY2022Q4	phm	Financial Services Debt FinancialServicesDebt	586711000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	2041637000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2045527000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5567233000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5882417000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9263809000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8914098000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14831042000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14796515000	usd
CY2023Q1	us-gaap	Revenues Revenues	3575641000	usd
CY2022Q1	us-gaap	Revenues Revenues	3149519000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	336518000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	329022000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2513000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1221000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1818000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3359000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	702122000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	599893000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	169863000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145170000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	532259000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	454723000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.35
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.84
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.35
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.16
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	225127000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	245796000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	830000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1069000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	225957000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	246865000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	532259000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	454723000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	25000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	25000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	532259000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	454748000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8914098000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4842000	usd
CY2023Q1	us-gaap	Dividends Dividends	36139000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	150000000	usd
CY2023Q1	phm	Excise Tax On Share Repurchase ExciseTaxOnShareRepurchase	1221000	usd
CY2023Q1	phm	Excise Tax On Share Repurchase ExciseTaxOnShareRepurchase	1221000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	10059000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10029000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	532259000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9263809000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7489515000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6030000	usd
CY2022Q1	us-gaap	Dividends Dividends	36512000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	500000000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	13614000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13097000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	454723000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	25000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7413264000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	532259000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	454723000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	28152000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13407000	usd
CY2023Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	5683000	usd
CY2022Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	3510000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19139000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16181000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2513000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1221000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3509000	usd
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12488000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16615000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-50000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-48000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	85408000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	814768000	usd
CY2023Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-256360000	usd
CY2022Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-436865000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-25053000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	35344000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-83404000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	117650000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	711368000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	207666000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23743000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30686000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1117000	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6681000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2216000	usd
CY2022Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	10400000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1570000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	199000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24214000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47966000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4500000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-262264000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-229985000	usd
CY2023Q1	phm	Proceeds Land Under Purchase Options Recorded ProceedsLandUnderPurchaseOptionsRecorded	18449000	usd
CY2022Q1	phm	Proceeds Land Under Purchase Options Recorded ProceedsLandUnderPurchaseOptionsRecorded	0	usd
CY2023Q1	phm	Payments Land Under Purchase Options Recorded PaymentsLandUnderPurchaseOptionsRecorded	10099000	usd
CY2022Q1	phm	Payments Land Under Purchase Options Recorded PaymentsLandUnderPurchaseOptionsRecorded	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	150000000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	500000000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10059000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13614000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	36380000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	37796000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-454853000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-781395000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	232301000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-621695000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1094553000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1833565000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1326854000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1211870000	usd
CY2023Q1	phm	Interestpaidcapitalizednet Interestpaidcapitalizednet	6205000	usd
CY2022Q1	phm	Interestpaidcapitalizednet Interestpaidcapitalizednet	5157000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	209000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1915000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsEffective with our first quarter 2023 reporting, we reclassified our closing cost incentives provided to customers, including seller-paid financing costs, from home sale cost of revenues to home sale revenues. All prior period amounts have been reclassified to conform to the current presentation. As a result, all sales incentives provided to customers are classified as a reduction of home sale revenues. This reclassification had the effect of reducing both home sale revenues and home sale cost of revenues by the amount of such closing cost incentives, which totaled $81.2 million and $38.1 million for the three months ended March 31, 2023 and 2022, respectively.
CY2023Q1	phm	Write Off Of Deposits And Pre Acquisition Costs WriteOffOfDepositsAndPreAcquisitionCosts	5683000	usd
CY2022Q1	phm	Write Off Of Deposits And Pre Acquisition Costs WriteOffOfDepositsAndPreAcquisitionCosts	3510000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2670000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2821000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	7096000	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	388000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	107000	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	86000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3182000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2670000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1818000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3359000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	796400000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	783600000	usd
CY2023Q1	phm	Contractassetinsurancerenewals Contractassetinsurancerenewals	61900000	usd
CY2022Q4	phm	Contractassetinsurancerenewals Contractassetinsurancerenewals	57300000	usd
CY2023Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	420600000	usd
CY2022Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	677200000	usd
CY2023Q1	us-gaap	Inventory Real Estate Mortgage Loans Held In Inventory InventoryRealEstateMortgageLoansHeldInInventory	420700000	usd
CY2022Q4	us-gaap	Inventory Real Estate Mortgage Loans Held In Inventory InventoryRealEstateMortgageLoansHeldInInventory	680500000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	20600000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	52400000	usd
CY2023Q1	phm	Incurred But Not Reported Percentage Of Liability Reserves IncurredButNotReportedPercentageOfLiabilityReserves	0.73
CY2023Q1	us-gaap	Maximum Length Of Time Hedged In Cash Flow Hedge1 MaximumLengthOfTimeHedgedInCashFlowHedge1	P90D
CY2023Q1	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	13654000	usd
CY2023Q1	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	14024000	usd
CY2022Q4	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	15780000	usd
CY2022Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	22590000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	532259000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	454723000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	126000	usd
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	218000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	2148000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	3061000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	529985000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	451444000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	2148000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	3061000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	2135000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	3045000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	529998000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	451460000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	225127000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	245796000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	830000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1069000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	225957000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	246865000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.35
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.84
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.35
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	Credit lossesWe are exposed to credit losses primarily through our vendors and insurance carriers. We assess and monitor each counterparty’s ability to pay amounts owed by considering contractual terms and conditions, the counterparty’s financial condition, macroeconomic factors, and business strategy.
CY2023Q1	phm	Assets In Scope Under Accounting Standards Codification326 AssetsInScopeUnderAccountingStandardsCodification326	208900000	usd
CY2022Q4	phm	Assets In Scope Under Accounting Standards Codification326 AssetsInScopeUnderAccountingStandardsCodification326	222900000	usd
CY2023Q1	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	5351112000	usd
CY2022Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	5440186000	usd
CY2023Q1	us-gaap	Land Available For Development LandAvailableForDevelopment	5346687000	usd
CY2022Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	5134432000	usd
CY2023Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	647228000	usd
CY2022Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	679341000	usd
CY2023Q1	phm	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	86850000	usd
CY2022Q4	phm	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	72058000	usd
CY2023Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	11431877000	usd
CY2022Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	11326017000	usd
CY2022Q4	us-gaap	Purchase Options Land PurchaseOptionsLand	478755000	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	137262000	usd
CY2021Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	160756000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	31802000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	31583000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	27793000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	33669000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	141271000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	158670000	usd
CY2023Q1	us-gaap	Purchase Options Land PurchaseOptionsLand	485727000	usd
CY2023Q1	phm	Remaining Purchase Price Of All Land Option Agreements RemainingPurchasePriceOfAllLandOptionAgreements	5537464000	usd
CY2022Q4	phm	Remaining Purchase Price Of All Land Option Agreements RemainingPurchasePriceOfAllLandOptionAgreements	5400241000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2023Q1	us-gaap	Revenues Revenues	3575641000	usd
CY2022Q1	us-gaap	Revenues Revenues	3149519000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	702122000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	599893000	usd
CY2023Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	5683000	usd
CY2022Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	3510000	usd
CY2023Q1	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	5351112000	usd
CY2023Q1	us-gaap	Land Available For Development LandAvailableForDevelopment	5346687000	usd
CY2023Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	647228000	usd
CY2023Q1	phm	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	86850000	usd
CY2023Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	11431877000	usd
CY2023Q1	us-gaap	Assets Assets	14831042000	usd
CY2022Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	5440186000	usd
CY2022Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	5134432000	usd
CY2022Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	679341000	usd
CY2022Q4	phm	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	72058000	usd
CY2022Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	11326017000	usd
CY2022Q4	us-gaap	Assets Assets	14796515000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9341000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9701000	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	1990659000	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	1990299000	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	50978000	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	55228000	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	55228000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	2041637000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2045527000	usd
CY2023Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2120458000	usd
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2079218000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	1300000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1800000000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	288800000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	961200000	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	303400000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	946600000	usd
CY2023Q1	us-gaap	Dividends Dividends	36100000	usd
CY2022Q1	us-gaap	Dividends Dividends	36500000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1000000000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	161300000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	133100000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	23600000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	4600000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	4100000	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	50978000	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	55228000	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	55228000	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	288800000	usd
CY2023Q1	phm	Surety Bonds Outstanding SuretyBondsOutstanding	2100000000	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	303400000	usd
CY2022Q4	phm	Surety Bonds Outstanding SuretyBondsOutstanding	2200000000	usd
CY2023Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	652700000	usd
CY2022Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	635900000	usd
CY2023Q1	phm	Maximum Product Warranty In Years MaximumProductWarrantyInYears	P10Y
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	108348000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	107117000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	20371000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	19692000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	24134000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	19674000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	1395000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-495000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	105980000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	106640000	usd
CY2022Q4	phm	Incurred But Not Reported Percentage Of Liability Reserves IncurredButNotReportedPercentageOfLiabilityReserves	0.74
CY2022Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	635857000	usd
CY2021Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	627067000	usd
CY2023Q1	phm	Additions To Self Insurance Reserves AdditionsToSelfInsuranceReserves	24121000	usd
CY2022Q1	phm	Additions To Self Insurance Reserves AdditionsToSelfInsuranceReserves	19837000	usd
CY2023Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	-564000	usd
CY2022Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	2139000	usd
CY2023Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	6669000	usd
CY2022Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	4765000	usd
CY2023Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	652745000	usd
CY2022Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	644278000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	72900000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	89400000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73500000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	90100000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3900000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	500000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5400000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5500000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	14200000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	12900000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	3000000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	2200000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4200000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5100000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	20806000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	23521000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	15765000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	11998000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9414000	usd
CY2023Q1	phm	Lessee Operating Lease Liabilitytobe Paidafter Year Four LesseeOperatingLeaseLiabilitytobePaidafterYearFour	15639000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	97143000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7724000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	89419000	usd
CY2023Q1	phm	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	2200000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.054

Files In Submission

Name	View Source	Status
0000822416-23-000017-index-headers.html	Edgar Link	pending
0000822416-23-000017-index.html	Edgar Link	pending
0000822416-23-000017.txt	Edgar Link	pending
0000822416-23-000017-xbrl.zip	Edgar Link	pending
exhibit31aceocertification.htm	Edgar Link	pending
exhibit31bcfocertification.htm	Edgar Link	pending
exhibit32-certification033.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
phm-20230331.htm	Edgar Link	pending
phm-20230331.xsd	Edgar Link	pending
phm-20230331_g1.jpg	Edgar Link	pending
phm-20230331_cal.xml	Edgar Link	unprocessable
phm-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
phm-20230331_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
phm-20230331_lab.xml	Edgar Link	unprocessable
phm-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHM
PULTEGROUP INC/MI/ Stock $phm

2023 Q2 Form 10-Q Financial Statement

#000082241623000017 Filed on April 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHM PULTEGROUP INC/MI/ Stock $phm

2023 Q2 Form 10-Q Financial Statement

#000082241623000017 Filed on April 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHM
PULTEGROUP INC/MI/ Stock $phm